# Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea

> **NCT01972932** · PHASE4 · TERMINATED · sponsor: **Bio-K Plus International Inc.** · enrollment: 60 (actual)

## Conditions studied

- Clostridium Difficile Infection
- Antibiotic Associated Diarrhea

## Interventions

- **DIETARY_SUPPLEMENT:** Bio K+® 2 capsules orally (or via nasogastric tube)
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT01972932
- **Lead sponsor:** Bio-K Plus International Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11
- **Primary completion:** 2014-11
- **Final completion:** 2017-08
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** Recruitment problems
- **Last updated:** 2022-07-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01972932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01972932, "Study of Bio-K+® in the Reduction of the Risk of Clostridium Difficile Infection and Antibiotic Associated Diarrhea". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01972932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*